CLINICAL_TRIALS
trial_result
· 2024-08-30
Clinical Trial Update: Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD) [Phase 1]
Summary
A Phase 1 trial evaluating the safety and dosing of EN001 in patients with Duchenne Muscular Dystrophy has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ENCell | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED